Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study
| Autor: | Alsamil, Ali M., Giezen, Thijs J., Egberts, Toine C., Leufkens, Hubert G., Gardarsdottir, Helga |
|---|---|
| Zdroj: | In Biologicals January 2021 69:30-37 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect